Evidence map›Paper›PMID 20179125›Full record

Trial reportBMJ (Clinical research ed.)2010

Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.

Kirsten J McCaffery, Les Irwig, Robin Turner, Siew Foong Chan, Petra Macaskill, Mary Lewicka, Judith Clarke, Edith Weisberg, Alex Barratt

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021
    Guideline
  3. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Sexually transmitted diseases treatment guidelines, 2015.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2015
    Guideline
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Psychological factors among Appalachian women with abnormal Pap results.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022
    Article
  11. Health-related quality of life in women after colposcopy: results from a longitudinal patient survey.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  12. Article
  13. Health-related quality of life of women after HPV testing as triage strategy for an abnormal Pap smear: a nested randomized pragmatic trial in a middle-income country.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Is quality of life a suitable measure of patient decision aid effectiveness? Sub-analysis of a Cochrane systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Review
  18. Article
  19. Psychosocial consequences of skin cancer screening.Preventive medicine reports · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kirsten J McCafferyScreening and Test Evaluation Program, School of Public Health, University of Sydney, NSW 2006, Australia. kirstenm@health.usyd.edu.au
Les Irwig
Robin Turner
Siew Foong Chan
Petra Macaskill
Mary Lewicka
Judith Clarke
Edith Weisberg
Alex Barratt
University of Sydney · AUFamily Planning NSW · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess which of three triage strategies for women with borderline abnormal cervical smear results in the best psychosocial outcomes.

designPragmatic, non-blinded, multicentre, randomised controlled trial.

setting18 family planning clinics across Australia, covering both urban and rural areas, between January 2004 and October 2006.

participantsWomen aged 16-70 years (n=314) who attended routine cervical screening and received a borderline cervical smear.

interventionsPatients were randomly assigned to human papillomavirus (HPV) DNA testing (n=104), a repeat smear test at six months (n=106), or the patient's informed choice of either test supported by a decision aid (n=104). Psychosocial outcomes were assessed at multiple time points over 12 months by postal questionnaire.

main outcome measuresWe assessed health related quality of life (SF36 mental health subscale), cognitive effects (such as perceived risk of cervical cancer, intrusive thoughts), affective outcomes (general anxiety [state-trait anxiety inventory]), specific anxiety about an abnormal smear (cervical screening questionnaire), and behavioural outcomes (sexual health behaviour and visits to the doctor) over 12 months of follow-up.

resultsAt two weeks, some psychosocial outcomes were worse for women allocated to HPV testing compared with those in the smear testing group (SF36 vitality subscale: t=-1.63, df=131, P=0.10; intrusive thoughts chi(2)=8.14, df=1, P<0.01). Over 12 months, distress about the abnormal smear was lowest in women allocated to HPV testing and highest in the repeat smear testing group (t=-2.89, df=135, P<0.01). Intrusive thoughts were highest in patients allocated to HPV testing (25%, compared with 13% in the informed choice group; difference=12%, 95% CI -1.1% to 25.1%). Women in the HPV DNA group and the informed choice group were more satisfied with their care than women allocated to repeat smear testing.

conclusionsAlthough the psychosocial effect was initially worse for women allocated to HPV triage, over the full year of follow-up this intervention was better for women's psychosocial health than repeat smear testing. Offering informed choice could have a small advantage for cognitive outcomes, but in view of the additional effort and logistical complexity that this intervention requires, HPV testing alone can be justified for most women.

trial registrationactr.org.au Identifier: 12605000111673.

Indexed as

AdolescentAdultAgedAnxietyCognition DisordersEpidemiologic MethodsFemaleHumansMiddle AgedPapillomavirus InfectionsPatient Acceptance of Health CarePatient SatisfactionPerceptionPrognosisQuality of LifeSexual Dysfunction, Physiological

Identifiers

PMID20179125
PMCPMC2827716
OpenAlexW1980078504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.